Skip to content

Exploring the biological mechanism of Ulcerative Colitis caused by dampness based on cross omics

Exploring the biological mechanism of Ulcerative Colitis caused by dampness based on cross omics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005840
Enrollment
Unknown
Registered
2022-04-10
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

UC?????:Nil
UC??????:Nil
?????:Nil

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy volunteers with no abnormal clinical manifestations; or those who meet the diagnostic criteria for patients with UC (left colon type, active, mild) dampness pattern and other non-damp syndromes; (2) Age between 18-70 years old; (3) Not taking antibiotics, steroids and other hormones, Chinese herbal medicine preparations (including oral and intravenous injection), probiotics such as probiotics or yogurt in the past week; (4) The patient signed the informed consent and was willing to accept the corresponding examination and treatment.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases; (2) Combined with other organic diseases of the digestive system (such as peptic ulcer), or systemic diseases that affect the motility of the digestive tract (such as hyperthyroidism, diabetes); (3) Those who are using or need to continue to use drugs that may affect gastrointestinal function (antidiarrheals, antidepressants, anti-anxiety drugs, intestinal flora regulators, antibiotics, etc.); (4) Those who have a history of allergy to related drugs used in the study and a history of severe food allergy.

Design outcomes

Primary

MeasureTime frame
metabolomics;Immunomics;genomics;Transcriptomics;

Countries

China

Contacts

Public ContactWU Haomeng

TCM prevention and treatment of functional gastrointestinal diseases research team

237925993@qq.com13560228339

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026